European Commission commits $1.8M grant for intraoperative cancer imaging

Kathy Mahdoubi | | Health Imaging | Molecular Imaging

An international consortium has been awarded a $1.8 million grant from the European Commission to assess Cerenkov luminescence imaging for intraoperative imaging of gastric cancer patients.

The grant bankrolls a two-year project named CLIO (Cerenkov luminescence imaging optimization) evaluating the technique in image-guided surgeries to resect gastrointestinal cancer. The monies come from the 7th Framework Program, a research-funding body of the European Commission. Lightpoint Medical, based in Rickmansworth, U.K., announced the award yesterday.

"At Lightpoint we're excited to be a part of a collaboration involving such high caliber collaborators in this Framework Program 7 project, kindly funded by the European Commission,” Ian Quirk, Lightpoint director of clinical and regulatory affairs, said in a statement. “Significantly improving outcomes in cancer surgery is at the core of everything Lightpoint strives to achieve and this project offers the opportunity to apply that ethos to gastric cancer."

The company will be overseeing the clinical trial in collaboration with the Frederic Joliot-Curie National Research Institute for Radiobiology and Radiation Health, Semmelweis University and CROmed Research in Budapest, Hungary; Sagentia product development based in Cambridge, England; and ABX CRO, a Dresden, Germany, biotech and pharmaceutical company.

Kathy Mahdoubi

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.